Influencia de la adaptación dietética individualizada en pacientes sometidos atrasplante de precursores hematopoyéticos / Estudio aDiTraS Infl uence of individualized dietary adaptation in patients undergoing hematopoietic stem cell transplantation. The ADITRAS study

Introducción: el objetivo del estudio fue valorar la eficacia de una adaptación dietética individualizada para conseguir los requerimientos nutricionales en pacientes sometidos a trasplante de precursores hematopoyéticos (TPH). Metodología: estudio piloto de intervención nutricional con pacientes sometidos a TPH. Se realizó una valoración nutricional en las primeras 24 horas de ingreso y cada 48 a 72 horas hasta el alta, o + 40 días del trasplante, realizando adaptaciones dietéticas. Resultados: se reclutaron 25 pacientes. Según el MUST, el 92,0 % (n = 23) se encontraban bien nutridos en la visita inicial, con una pérdida de 2,1 (3,8) kg y un IMC de 26,4 kg/m2 (4,2). Antes del TPH ya hubo una disminución de la ingesta del 15,4 (23,5) % y del peso corporal de 0,2 (3,2) kg; tras el TPH, la pérdida de peso fue de 3,4 (5,0) kg y la disminución de la ingesta del 6,5 (30,4) %. Los síntomas predominantes fueron mucositis (60 %), náuseas (60 %) y diarrea (44 %). Se adaptó la dieta en el 100 % de los pacientes y el 52 % recibieron soporte nutricional oral (SNO) (n = 13), mientras que la nutrición enteral (NE) y la nutrición parenteral (NP) se utilizaron solo 1 vez. Conclusión: el estado nutricional de los pacientes sometidos a TPH es normal al ingreso pero se deteriora durante la realización del trasplante y su acondicionamiento previo. La intervención dietética es clave para mantener la ingesta oral y disminuir el riesgo de desnutrición.(AU)

Introduction: the objective of the study was to assess the effi cacy of an individualized dietary adaptation to achieve nutritional requirements in patients undergoing hematopoietic stem cell transplantation (HSCT). Methodology: a pilot study of a nutritional intervention in patients undergoing HSCT. A nutritional assessment was performed the fi rst 24 hours of admission and every 48-72 hours until discharge, or + 40 days after the transplant, making dietary adaptations. Results: 25 patients were recruited. According to MUST, 92.0 % (n = 23) were well nourished at the initial visit, with a loss of 2.1 (3.8) kg and a BMI of 26.4 kg/m2 (4.2). Before HSCT, there was already a decrease in intake of 15.4 (23.5) % and in body weight of 0.2 (3.2) kg; after the HSCT, the weight loss was 3.4 (5.0) kg and the decrease in intake was 6.5 (30.4) %. The predominant symptoms were mucositis (60 %), nausea (60 %), and diarrhea (44 %). The diet was adapted in 100 % of the patients, 52 % received oral nutritional support (ONS) (n = 13); enteral nutrition (EN) and parenteral nutrition (PN) were used only once. Conclusion: the nutritional status of patients undergoing HSCT is normal on admission but deteriorates during transplantation and prior conditioning. Dietary intervention is key to maintaining oral intake and reducing the risk of malnutrition.(AU)

[Influence of individualized dietary adaptation in patients undergoing hematopoietic stem cell transplantation. The ADITRAS study]. / Influencia de la adaptación dietética individualizada en pacientes sometidos a trasplante de precursores hematopoyéticos. Estudio ADITRAS.

Introduction: Introduction: the objective of the study was to assess the efficacy of an individualized dietary adaptation to achieve nutritional requirements in patients undergoing hematopoietic stem cell transplantation (HSCT). Methodology: a pilot study of a nutritional intervention in patients undergoing HSCT. A nutritional assessment was performed the first 24 hours of admission and every 48-72 hours until discharge, or + 40 days after the transplant, making dietary adaptations. Results: 25 patients were recruited. According to MUST, 92.0 % (n = 23) were well nourished at the initial visit, with a loss of 2.1 (3.8) kg and a BMI of 26.4 kg/m2 (4.2). Before HSCT, there was already a decrease in intake of 15.4 (23.5) % and in body weight of 0.2 (3.2) kg; after the HSCT, the weight loss was 3.4 (5.0) kg and the decrease in intake was 6.5 (30.4) %. The predominant symptoms were mucositis (60 %), nausea (60 %), and diarrhea (44 %). The diet was adapted in 100 % of the patients, 52 % received oral nutritional support (ONS) (n = 13); enteral nutrition (EN) and parenteral nutrition (PN) were used only once. Conclusion: the nutritional status of patients undergoing HSCT is normal on admission but deteriorates during transplantation and prior conditioning. Dietary intervention is key to maintaining oral intake and reducing the risk of malnutrition.

Introducción: Introducción: el objetivo del estudio fue valorar la eficacia de una adaptación dietética individualizada para conseguir los requerimientos nutricionales en pacientes sometidos a trasplante de precursores hematopoyéticos (TPH). Metodología: estudio piloto de intervención nutricional con pacientes sometidos a TPH. Se realizó una valoración nutricional en las primeras 24 horas de ingreso y cada 48 a 72 horas hasta el alta, o + 40 días del trasplante, realizando adaptaciones dietéticas. Resultados: se reclutaron 25 pacientes. Según el MUST, el 92,0 % (n = 23) se encontraban bien nutridos en la visita inicial, con una pérdida de 2,1 (3,8) kg y un IMC de 26,4 kg/m2 (4,2). Antes del TPH ya hubo una disminución de la ingesta del 15,4 (23,5) % y del peso corporal de 0,2 (3,2) kg; tras el TPH, la pérdida de peso fue de 3,4 (5,0) kg y la disminución de la ingesta del 6,5 (30,4) %. Los síntomas predominantes fueron mucositis (60 %), náuseas (60 %) y diarrea (44 %). Se adaptó la dieta en el 100 % de los pacientes y el 52 % recibieron soporte nutricional oral (SNO) (n = 13), mientras que la nutrición enteral (NE) y la nutrición parenteral (NP) se utilizaron solo 1 vez. Conclusión: el estado nutricional de los pacientes sometidos a TPH es normal al ingreso pero se deteriora durante la realización del trasplante y su acondicionamiento previo. La intervención dietética es clave para mantener la ingesta oral y disminuir el riesgo de desnutrición.

High-dose Vitamin C supplementation in the treatment of patients with COVID-19: A systematic review

Introduction: Vitamin C supplementation has been seen as a supportive treatment to control and prevent complications of COVID-19 by enhancing the immune response against infection. However, the effects of high doses of this vitamin are not yet fully understood. Objective: To analyze the effects of high-dose vitamin C in patients with COVID-19. Methods: This was a systematic review, using original studies published from April 2020 to November 2022 in PubMed, ScienceDirect, Scopus and Web of Science databases. The combination of descriptors registered in Medical Subject Headings (MeSH) used to search for articles were: (("vitamin C" OR "ascorbic acid") AND ("COVID-19" OR "SARS-CoV-2" OR "coronavirus")). Original articles of clinical trials conducted with patients diagnosed with COVID-19 and submitted to high-dose vitamin C supplementation were included. Results: Eligible studies included patients in intensive care units, wards, or outpatient clinics, who were given doses of vitamin C, ranging from 6,000 to 8,000 mg/day, with an average duration of 6.25 days of supplementation and mostly intravenous administration. A reduction in fever and myalgia was observed, as well as an improvement in oxygen saturation and lung impairment rate. Conclusion: The role of high-dose vitamin C in patients affected by COVID-19 requires further study, however, to date, the results have been promising for symptom reduction and improvement in lung function and oxygenation.

Introducción: La administración de suplementos de vitamina C se ha considerado un tratamiento de apoyo para controlar y prevenir las complicaciones del COVID-19 al mejorar la respuesta inmunitaria contra la infección. Sin embargo, los efectos de dosis elevadas de esta vitamina aún no se conocen en su totalidad. Objetivo: Analizar los efectos de altas dosis de vitamina C en pacientes con COVID-19. Métodos: Se trata de un estudio de revisión sistemática, utilizando artículos originales publicados desde abril de 2020 hasta noviembre de 2022 en las bases de datos PubMed, ScienceDirect, Scopus y Web of Science. Para la búsqueda de los artículos se utilizó la combinación de descriptores registrados en Medical Subject Headings (MeSH): (("vitamin C" OR "ascorbic acid") AND ("COVID-19" OR "SARS-CoV-2" OR "coronavirus")). Se incluyeron artículos originales de tipo ensayo clínico realizados con pacientes diagnosticados con COVID-19 y sometidos a suplementación con altas dosis de vitamina C. Resultados: Los estudios elegibles se realizaron con pacientes ingresados en unidades de cuidados intensivos, salas o ambulatorios, a los que se administraron dosis de vitamina C que oscilaban entre 6.000 y 8.000 mg/día, con una duración media de 6,25 días de suplementación y vía de administración mayoritariamente intravenosa. Se observó una reducción de la fiebre y las mialgias, además de una mejoría de la saturación de oxígeno y de la tasa de compromiso pulmonar. Conclusión: El papel de las dosis altas de vitamina C en pacientes afectados por COVID-19 requiere más estudios; sin embargo, hasta la fecha, los resultados han sido prometedores en cuanto a la reducción de los sintomas, y la mejora de la función pulmonar y la oxigenación.

Prevalencia, hábitos de consumo y complicaciones de los suplementos nutricionales proteicos en adolescentes / Protein supplement consumption prevalence, habits and complications in adolescents

Introducción: El consumo de suplementos nutricionales y proteicos por adolescentes puede tener importantes repercusiones para su salud. Material y método: Estudio prospectivo observacional, basado en una encuesta, dirigido a los adolescentes de seis colegios, seleccionados aleatoriamente, de la ciudad de Sevilla. Nuestro objetivo principal es conocer el consumo real de suplementos alimentarios entre la población adolescente, cuantificando su contenido proteico. Resultados: Se obtuvieron 263 respuestas válidas, objetivando una prevalencia de consumo de 19,01% para todos los suplementos nutricionales, de ellos 56,0% tomaban suplementos de proteínas (10,64% del total), con una ingesta media de estas últimas de 0,26±0,18 g/kg/día. El perfil del consumidor de cualquier tipo de suplementos se diferencia del de los que no los utilizan en la edad, el uso de medicación habitual y realizar dieta para perder peso o hiperproteica. Al comparar los adolescentes que ingerían productos proteicos con los no proteicos, la única variación significativa estuvo en el control del consumo. Aunque la mayoría no tiene control externo, en 25,92% de los que tomaban proteínas el seguimiento lo hacía un profesional, vs. 7,38% de los que ingerían suplementos no proteicos. De los consumidores de productos proteicos, 85,18% consiguió el objetivo buscado y 18,51% refirió algún efecto negativo. Conclusiones: La prevalencia de consumo de suplementos proteicos entre los adolescentes de nuestro medio es del 10,64%, en cantidades que suponen un 25% de las proteínas que deben ingerir diariamente. El perfil de consumidor de suplementos proteicos es muy similar al de aquel que toma productos no proteicos. (AU)

Introduction: The consumption of nutritional and protein supplements by adolescents may have important consequences for their health. Material and methods: Prospective observational study based on a survey of adolescents enrolled in six schools selected at random in the city of Seville. Our primary objective was to determine the actual consumption of dietary supplements in the adolescent population and quantifying their protein content. Results: We obtained a total of 263 valid responses that showed a prevalence of consumption of nutritional supplements of any kind of 19.01%, of which 56.0% (10.64% of the total) corresponded to adolescents that consumed protein supplements for a mean protein intake of 0.26 g/kg/day (SD, 0.18). The profile of consumers of any type of supplements differed from that of nonconsumers in age, use of long-term medication and weight loss or high-protein diets. The comparison of adolescents who consumed protein supplements versus nonprotein supplements only evinced a significant difference in the control of supplement consumption. Although most of these adolescents were not subject to external control, 25.92% of those who consumed protein supplements were monitored by a professional, compared to 7.38% of consumers of nonprotein supplements. In the group that consumed protein supplements, 85.18% of adolescents achieved the desired effect and 18.51% reported some form of negative effect. Conclusions: The prevalence of protein supplement consumption among adolescents in our area is 10.64%, with consumption of amounts corresponding to 25% of the recommended daily allowance of protein. The profile of protein supplement consumers is very similar to that of nonprotein supplement consumers. (AU)

Protein supplement consumption prevalence, habits and complications in adolescents.

INTRODUCTION: The consumption of nutritional and protein supplements by adolescents may have important consequences for their health. METHODS: Prospective observational study based on a survey of adolescents enrolled in 6 schools selected at random in the city of Seville. Our primary objective was to determine the actual consumption of dietary supplements in the adolescent population and quantifying their protein content. RESULTS: We obtained a total of 263 valid responses that showed a prevalence of consumption of nutritional supplements of any kind of 19.01%, of which 56.0% (10.64% of the total) corresponded to adolescents that consumed protein supplements for a mean protein intake of 0.26 g/kg/day (SD, 0.18). The profile of consumers of any type of supplements differed from that of nonconsumers in age, use of long-term medication and weight loss or high-protein diets. The comparison of adolescents who consumed protein supplements versus nonprotein supplements only evinced a significant difference in the control of supplement consumption. Although most of these adolescents were not subject to external control, 25.92% of those who consumed protein supplements were monitored by a professional, compared to 7.38% of consumers of nonprotein supplements. In the group that consumed protein supplements, 85.18% of adolescents achieved the desired effect and 18.51% reported some form of negative effect. CONCLUSIONS: The prevalence of protein supplement consumption among adolescents in our area is 10.64%, with consumption of amounts corresponding to 25% of the recommended daily allowance of protein. The profile of protein supplement consumers is very similar to that of nonprotein supplement consumers.

Evaluación de las características organolépticas de un suplemento nutricional oral diseñado específicamente para el paciente oncológico / Evaluation of the organoleptic characteristics of an oral nutritional supplement designed specifically for the cancer patient

Introducción: los suplementos nutricionales orales (SNO) son una de las terapias nutricionales más utilizadas para tratar la desnutrición en los pacientes oncológicos. Por ello, es de gran importancia contar con la innovación en estos tratamientos, desde los nutrientes hasta la calidad sensorial, para asegurar su consumo. Objetivos: evaluar las características organolépticas de diferentes prototipos de SNO diseñados específicamente para pacientes oncológicos. Métodos: estudio clínico piloto transversal, aleatorizado, cruzado y doble ciego en pacientes con cualquier tipo de cáncer, con o sin tratamiento oncológico, a los que se les realizó una cata de cinco prototipos de SNO con distintos sabores (brownie, tropical, piña, tomate y jamón) y distintas cualidades sensoriales para evaluar sus características organolépticas (color, olor, sabor, gusto residual, textura y densidad) a través de un cuestionario específico. Resultados: treinta pacientes de 67,5 ± 11,2 años y con un índice de masa corporal (IMC) de 22,3 ± 3,52 kg/m2 fueron evaluados. Los tumores más prevalentes fueron cabeza y cuello (30 %), páncreas (20 %) y colorrectal (17 %). El 65 % de los pacientes había perdido ≥ 10 % del peso corporal en seis meses. Los SNO mejor valorados fueron los sabores brownie (23,67 ± 3,91 puntos) y tropical (20,33 ± 3,37 puntos) mientras que los menos valorados fueron los SNO con sabor tomate (16,33 ± 5,44 puntos) y jamón (13,97 ± 4,64 puntos). Conclusión: los pacientes oncológicos valoran de forma mucho más positiva las características organolépticas de los SNO con sabores dulces, como el brownie, y los sabores afrutados, como el tropical. Menos apreciados por este colectivo son aquellos con un sabor salado, como el sabor jamón y tomate. (AU)

Introduction: oral nutritional supplements (ONS) are nutritional therapies used to treat malnutrition in cancer patients, therefore, innovation in these treatments, from nutrients to sensory quality, is essential to ensure their consumption. Objectives: to evaluate the organoleptic characteristic of different prototypes of oral nutritional supplements specifically designed for cancer patients. Method: cross-sectional, randomized, double-blind pilot clinical study in patients with any type of cancer, with or without oncological treatment,who tasted five ONS prototypes with different flavors (brownie, tropical, pineapple, tomato and ham) and different sensory qualities in order to evaluate their organoleptic characteristics (color, smell, taste, residual taste, texture and density) through a specific questionnaire. Results: thirty patients aged 67.5 ± 11.2 years and body mass index (BMI) of 22.3 ± 3.52 kg/m2 were evaluated. The most prevalent tumors were head and neck (30 %), pancreas (20 %) and colon (17 %); 65 % of the patients had lost ≥ 10 % of their body weight in six months. The best rated supplements by the cancer population were those with brownie flavor (23.67 ± 3.91 points) and tropical (20.33 ± 3.37 points), while the least valued were tomato (16.33 ± 5.44 points) and ham flavor (13.97 ± 4.64 points). Conclusions: cancer patients value the organoleptic characteristics of ONS with sweet flavors, such as brownie, and fruity flavors, such as tropical, much more positively. Less appreciated by these patients are those with a salty taste, such as ham and tomato flavor. (AU)

[Evaluation of the organoleptic characteristics of an oral nutritional supplement designed specifically for the cancer patient]. / Evaluación de las características organolépticas de un suplemento nutricional oral diseñado específicamente para el paciente oncológico.

Introduction: Introduction: oral nutritional supplements (ONS) are nutritional therapies used to treat malnutrition in cancer patients, therefore, innovation in these treatments, from nutrients to sensory quality, is essential to ensure their consumption. Objectives: to evaluate the organoleptic characteristic of different prototypes of oral nutritional supplements specifically designed for cancer patients. Method: cross-sectional, randomized, double-blind pilot clinical study in patients with any type of cancer, with or without oncological treatment, who tasted five ONS prototypes with different flavors (brownie, tropical, pineapple, tomato and ham) and different sensory qualities in order to evaluate their organoleptic characteristics (color, smell, taste, residual taste, texture and density) through a specific questionnaire. Results: thirty patients aged 67.5 ± 11.2 years and body mass index (BMI) of 22.3 ± 3.52 kg/m2 were evaluated. The most prevalent tumors were head and neck (30 %), pancreas (20 %) and colon (17 %); 65 % of the patients had lost ≥ 10 % of their body weight in six months. The best rated supplements by the cancer population were those with brownie flavor (23.67 ± 3.91 points) and tropical (20.33 ± 3.37 points), while the least valued were tomato (16.33 ± 5.44 points) and ham flavor (13.97 ± 4.64 points). Conclusions: cancer patients value the organoleptic characteristics of ONS with sweet flavors, such as brownie, and fruity flavors, such as tropical, much more positively. Less appreciated by these patients are those with a salty taste, such as ham and tomato flavor.

Introducción: Introducción: los suplementos nutricionales orales (SNO) son una de las terapias nutricionales más utilizadas para tratar la desnutrición en los pacientes oncológicos. Por ello, es de gran importancia contar con la innovación en estos tratamientos, desde los nutrientes hasta la calidad sensorial, para asegurar su consumo. Objetivos: evaluar las características organolépticas de diferentes prototipos de SNO diseñados específicamente para pacientes oncológicos. Métodos: estudio clínico piloto transversal, aleatorizado, cruzado y doble ciego en pacientes con cualquier tipo de cáncer, con o sin tratamiento oncológico, a los que se les realizó una cata de cinco prototipos de SNO con distintos sabores (brownie, tropical, piña, tomate y jamón) y distintas cualidades sensoriales para evaluar sus características organolépticas (color, olor, sabor, gusto residual, textura y densidad) a través de un cuestionario específico. Resultados: treinta pacientes de 67,5 ± 11,2 años y con un índice de masa corporal (IMC) de 22,3 ± 3,52 kg/m2 fueron evaluados. Los tumores más prevalentes fueron cabeza y cuello (30 %), páncreas (20 %) y colorrectal (17 %). El 65 % de los pacientes había perdido ≥ 10 % del peso corporal en seis meses. Los SNO mejor valorados fueron los sabores brownie (23,67 ± 3,91 puntos) y tropical (20,33 ± 3,37 puntos) mientras que los menos valorados fueron los SNO con sabor tomate (16,33 ± 5,44 puntos) y jamón (13,97 ± 4,64 puntos). Conclusión: los pacientes oncológicos valoran de forma mucho más positiva las características organolépticas de los SNO con sabores dulces, como el brownie, y los sabores afrutados, como el tropical. Menos apreciados por este colectivo son aquellos con un sabor salado, como el sabor jamón y tomate.

Avaliação nutricional de pacientes cirúrgicos com câncer gastrointestinal em uso de suplemento alimentar / Nutritional evaluation of surgical patients with gastrointestinal cancer using food supplements

Objetivo: Avaliar a nutrição de pacientes cirúrgicos com neoplasia no trato gastrointestinal em uso de suplemento alimentar. Método: Trata-se de uma revisão sistemática de literatura realizada nas bases de dados Google Scholar, PubMed, Scielo e Web of Science, no período de maio a junho de 2021, sem recorte temporal ou restrição de idioma, através dos descritores: "enteral nutrition e immunenutrition", "cancerpatients e gastriccancerpatients", "preoperative, perioperative e postoperative". Resultados: Foram selecionados 8 estudos, destes, a maioria identificou benefícios na utilização da suplementação em razão da diminuição de células TNF-a, do cortisol e da transferrina, diminuindo o tempo de internação e melhora no estado funcional dos participantes suplementados. Conclusão: Os achados foram positivos, no entanto, houve algumas limitações como a heterogeneidade em abordagens terapêuticas e perda de pacientes durante o estudo, apesar de apresentarem baixo risco de viés, ainda há a necessidade de mais estudos.(AU)

Objective: To evaluate the nutrition of surgical patients with neoplasia in the gastrointestinal tract using food supplements. Method: This is a systematic literature review carried out in Google Scholar, PubMed, Scielo and Web of Science databases, from May to June 2021, without time frame or language restriction, using the descriptors: "enteral nutrition and immunenutrition", "cancerpatients and gastriccancerpatients", "preoperative, perioperative and postoperative". Results: Eight studies were selected, most of which identified benefits in the use of supplementation due to the decrease in TNF-a cells, cortisol and transferrin, reducing the length of hospital stay and improving the functional status of supplemented participants. Conclusion: The findings were positive, however, there were some limitations such as heterogeneity in therapeutic approaches and loss of patients during the study, despite having a low risk of bias, there is still a need for further studies(AU)

Objetivo: Evaluar la nutrición de pacientes quirúrgicos con neoplasia en el tracto gastrointestinal utilizando suplementos alimenticios. Método: Se trata de una revisión sistemática de la literatura realizada en las bases de datos Google Scholar, PubMed, Scielo y Web of Science, de mayo a junio de 2021, sin franja horaria ni restricción de idioma, utilizando los descriptores: "nutrición enteral e inmunonutrición", "pacientes oncológicos y pacientes con cáncer gástrico", "preoperatorio, perioperatorio y postoperatorio". Resultados: Se seleccionaron ocho estudios, la mayoría de los cuales identificaron beneficios en el uso de la suplementación por la disminución de células TNF-a, cortisol y transferrina, reduciendo la estancia hospitalaria y mejorando el estado funcional de los participantes suplementados. Conclusión: Los hallazgos fueron positivos, sin embargo, hubo algunas limitaciones como la heterogeneidad en los enfoques terapéuticos y la pérdida de pacientes durante el estudio, a pesar de tener un bajo riesgo de sesgo, aún existe la necesidad de realizar más estudios(AU)

Avaliação nutricional de pacientes cirúrgicos com câncer gastrointestinal em uso de suplemento alimentar / Evaluación nutritional de pacientes quirúrgicos con cáncer gastrointestinal utilizando complementos alimentarios / Nutritional evaluation of surgical patients with gastrointestinal cancer using food supplements

Objetivo: Avaliar a nutrição de pacientes cirúrgicos com neoplasia no trato gastrointestinal em uso de suplemento alimentar. Método: Trata-se de uma revisão sistemática de literatura realizada nas bases de dados Google Scholar, PubMed, Scielo e Web of Science, no período de maio a junho de 2021, sem recorte temporal ou restrição de idioma, através dos descritores: "enteral nutrition e immunenutrition", "cancerpatients e gastriccancerpatients", "preoperative, perioperative e postoperative". Resultados: Foram selecionados 8 estudos, destes, a maioria identificou benefícios na utilização da suplementação em razão da diminuição de células TNF-a, do cortisol e da transferrina, diminuindo o tempo de internação e melhora no estado funcional dos participantes suplementados. Conclusão: Os achados foram positivos, no entanto, houve algumas limitações como a heterogeneidade em abordagens terapêuticas e perda de pacientes durante o estudo, apesar de apresentarem baixo risco de viés, ainda há a necessidade de mais estudos.(AU)

Objective: To evaluate the nutrition of surgical patients with neoplasia in the gastrointestinal tract using food supplements. Method: This is a systematic literature review carried out in Google Scholar, PubMed, Scielo and Web of Science databases, from May to June 2021, without time frame or language restriction, using the descriptors: "enteral nutrition and immunenutrition", "cancerpatients and gastriccancerpatients", "preoperative, perioperative and postoperative". Results: Eight studies were selected, most of which identified benefits in the use of supplementation due to the decrease in TNF-a cells, cortisol and transferrin, reducing the length of hospital stay and improving the functional status of supplemented participants. Conclusion: The findings were positive, however, there were some limitations such as heterogeneity in therapeutic approaches and loss of patients during the study, despite having a low risk of bias, there is still a need for further studies.(AU)

Objetivo: Evaluar la nutrición de pacientes quirúrgicos con neoplasia en el tracto gastrointestinal utilizando suplementos alimenticios. Método: Se trata de una revisión sistemática de la literatura realizada en las bases de datos Google Scholar, PubMed, Scielo y Web of Science, de mayo a junio de 2021, sin franja horaria ni restricción de idioma, utilizando los descriptores: "nutrición enteral e inmunonutrición", "pacientes oncológicos y pacientes con cáncer gástrico", "preoperatorio, perioperatorio y postoperatorio". Resultados: Se seleccionaron ocho estudios, la mayoría de los cuales identificaron beneficios en el uso de la suplementación por la disminución de células TNF-a, cortisol y transferrina, reduciendo la estancia hospitalaria y mejorando el estado funcional de los participantes suplementados. Conclusión: Los hallazgos fueron positivos, sin embargo, hubo algunas limitaciones como la heterogeneidad en los enfoques terapéuticos y la pérdida de pacientes durante el estudio, a pesar de tener un bajo riesgo de sesgo, aún existe la necesidad de realizar más estudios.(AU)

Effects of treatment with monacolin K, berberine and coenzyme Q10 on lipid metabolism in patients with moderate cardiovascular risk / Efectos del tratamiento con un suplemento nutricional a base de monacolina K, berberina y coenzima Q10 (lipoK®) sobre el metabolismo lipídico en pacientes con hipercolesterolemia y riesgo cardiovascular moderado

Objective The use of nutritional supplements to treat hypercholesterolemia is gradually increasing, however further studies on their efficacy and safety are required. Patients and methods The present clinical trial included patients with moderate hypercholesterolemia and cardiovascular risk who were treated either with a nutraceutical preparation containing 3.75mg of monacolin K, 515mg of berberine and 50mg of coenzyme Q10 per tablet (Lipok®) or with a placebo. The clinical and laboratory variables were analyzed at baseline and at three and six months. None of the patients was diabetic, and none was being treated with lipid-lowering drugs or with any other nutritional supplements affecting lipid metabolism. Results In patients of the intervention group and of the placebo group, baseline LDL-C was 134.7mg/dL (14.4) and 138.7mg/dL (15.2), respectively. At three months after treatment start, LDL-C had decreased by 26.1mg/dL (−32.4 to 19.7) and increased by 4.5mg/dL (−1.5 to 10.5) in the respective groups. In the intervention group, a similar decrease in non-HDL-C and total cholesterol was observed, while no significant changes were observed in either group for HDL-C, triglycerides and lipoprotein(a). A good tolerance and safety profile was observed. Conclusion In conclusion, this study demonstrates that the combination of monacolin K, berberine and coenzyme Q10 is effective and safe for treating hypercholesterolemia in patients with a moderate degree of excess LDL-C and cardiovascular risk (AU)

Objetivo El uso de suplementos nutricionales para tratar la hipercolesterolemia está aumentando de forma progresiva; sin embargo son necesarios más estudios sobre su eficacia y seguridad. Pacientes y métodos En el presente ensayo clínico fueron incluidos pacientes con hipercolesterolemia y riesgo cardiovascular moderados que fueron tratados con un preparado nutracéutico que contenía 3,75mg de monacolina K, 515mg de berberina y 50mg de coenzima Q10 por comprimido (Lipok®) o con placebo. Se analizaron las variables clínicas y de laboratorio en situación basal y a los 3 y 6 meses. Ningún paciente era diabético y ninguno seguía tratamiento con fármacos hipolipidemiantes u otros suplementos nutricionales con efectos sobre el metabolismo lipídico. Resultados En los pacientes del grupo de intervención y del grupo placebo, el c-LDL basal era de 134,7mg/dL (14,4) y 138,7mg/dL (15,2), respectivamente. A los 3 meses de tratamiento el c-LDL había disminuido 26,1mg/dL (de –32,4 a 19,7) y aumentado 4,5mg/dL (de –1,5 a 10,5) en ambos grupos, respectivamente. En el grupo de intervención se observó un descenso similar del c-no HDL y del colesterol total, mientras que no ocurrieron cambios significativos en ninguno de los 2 grupos en el c-HDL, los triglicéridos y la lipoproteína (a). Se observó un buen perfil de tolerancia y seguridad. Conclusión Este estudio demuestra que la combinación de monacolina K, berberina y coenzima Q10 es eficaz y segura para tratar la hipercolesterolemia en los pacientes con un grado de exceso de c-LDL y de riesgo cardiovascular moderados (AU)

Effects of treatment with monacolin K, berberine and coenzyme Q10 on lipid metabolism in patients with moderate cardiovascular risk.

OBJECTIVE: The use of nutritional supplements to treat hypercholesterolemia is gradually increasing, however further studies on their efficacy and safety are required. PATIENTS AND METHODS: The present clinical trial included patients with moderate hypercholesterolemia and cardiovascular risk who were treated either with a nutraceutical preparation containing 3.75mg of monacolin K, 515mg of berberine and 50mg of coenzyme Q10 per tablet (Lipok®) or with a placebo. The clinical and laboratory variables were analyzed at baseline and at three and six months. None of the patients was diabetic, and none was being treated with lipid-lowering drugs or with any other nutritional supplements affecting lipid metabolism. RESULTS: In patients of the intervention group and of the placebo group, baseline LDL-C was 134.7mg/dL (14.4) and 138.7mg/dL (15.2), respectively. At three months after treatment start, LDL-C had decreased by 26.1mg/dL (-32.4 to 19.7) and increased by 4.5mg/dL (-1.5 to 10.5) in the respective groups. In the intervention group, a similar decrease in non-HDL-C and total cholesterol was observed, while no significant changes were observed in either group for HDL-C, triglycerides and lipoprotein(a). A good tolerance and safety profile was observed. CONCLUSION: In conclusion, this study demonstrates that the combination of monacolin K, berberine and coenzyme Q10 is effective and safe for treating hypercholesterolemia in patients with a moderate degree of excess LDL-C and cardiovascular risk.

Can oral nutritional supplements increase energy and protein intake among hospitalized patients? / ¿Los suplementos nutricionales orales pueden aumentar la energía y la proteína en pacientes hospitalizados?

ABSTRACT Background: Oral nutritional supplements aim at offsetting dietary deficits and helping to meet energy and protein targets. Due to the absence of data about their role in food intake, it is necessary to evaluate the contribution of these products to the estimated needs of hospitalized patients. Methods: This is a prospective longitudinal study with hospitalized patients over 18 years of age, admitted to a public university hospital, who were given oral nutritional supplements, according to clinical guidelines. Food intake was quantified throughout the period such products were prescribed. Results: 805-day food intake follow-up and record of 128 patients, who took supplements for 6.4 days on average. The use of nutritional supplements demonstrated a significant contribution to the input of both energy (1576 kcal/day versus 1263 kcal/day, p<0.001) and protein (68.7 g/day versus 50.3 g/day, p<0.001). Conclusions: Nutritional supplements help increase food intake and achieve nutritional goals when prescribed in a hospital setting.

RESUMEN Antecedentes: los suplementos nutricionales orales tienen como objetivo compensar los déficits dietéticos y ayudar a cumplir los objetivos de energía y proteínas. Debido a la ausencia de datos sobre su papel en la ingesta de alimentos, es necesario evaluar la contribución de estos productos a las necesidades estimadas de los pacientes hospitalizados. Métodos: Este es un estudio longitudinal prospectivo con pacientes hospitalizados mayores de 18 años, ingresados en un hospital universitario público, que recibieron suplementos nutricionales orales, según la derivación clínica. La ingesta de alimentos se cuantificó durante todo el período en que se prescribieron dichos productos. Resultados: seguimiento de la ingesta alimentaria de 805 días y registro de 128 pacientes, que tomaron suplementos durante 6,4 días en promedio. El uso de suplementos nutricionales demostró una contribución significativa al aporte de energía (1576 kcal/día versus 1263 kcal/día, p< 0,001) y proteína (68,7 g/día versus 50,3 g/día, p<0,001). Conclusiones: los suplementos nutricionales ayudan a aumentar la ingesta de alimentos y alcanzar objetivos nutricionales cuando se prescriben en un entorno hospitalario.

Effect of an oral supplementation with a formula containing R-lipoic acid in glaucoma patients. / Efecto de la suplementación oral con una fórmula que contiene ácido R-lipoico en pacientes con glaucoma.

OBJECTIVE: To analyse the safety and effectiveness of the oral administration of a commercialised supplement containing R-alpha lipoic acid, taurine, vitamins C and E, lutein, zeaxanthin, zinc, copper and docosahexaenoic acid, in patients with primary open angle glaucoma (POAG), and in control subjects. MATERIAL AND METHODS: A prospective study of cases and controls was carried out, including 30 participants of both genders that were divided into: POAG Group (n=15) and a control group (CG; n=15), assigned to the oral intake of NuaDHA preparations Vision® (1 pill/day)+NuaDHA 1000 (2 pills/day) for 6 months. Participants were interviewed, ophthalmologically examined, and peripheral blood was taken for routine analysis and the determination of the pro-oxidant (malondialdehyde) and total antioxidant status. Statistical analysis was performed using the SPSS 22.0 program. RESULTS: After 6 months of supplementation, there was a significant increase in the plasma total antioxidant status (1.073±0.090mM vs 1.276±0.107mM, P=.028), along with a parallel decrease in malondialdehyde (7.066±1.070µM vs 2.771±0.462µM, P=.005) in the POAG group. The malondialdehyde also decreased in the control group (6.17±1.336 vs. 2.51±0.391, P=.028). The Schirmer test improved (20-30%) and the subjective dry eye signs/symptoms noticeably decreased in the POAG group versus the CG. CONCLUSIONS: Formulations containing antioxidant vitamins, R-alpha lipoic acid and docosahexaenoic acid, administered for 6 consecutive months, counteracted the oxidative stress by further stabilising the morphological/functional parameters of both the ocular surface and the glaucoma, without presenting with adverse effects or intolerances.

[The role of nutrition in the recovery of a basketball player]. / Papel de la nutrición en la recuperación del jugador de baloncesto.

INTRODUCTION: Introduction: very few works offer a practical solution to understand the nutritional requirements of current basketball. This work offers a theoretical-practical proposal. Objectives: to analyze the fatigue produced during a basketball game and offer a practical solution to accelerate recovery through nutrition. Methods: a search of the PubMed bibliographic database for reviews from the last 15 years and original articles from the last 5 years on basketball. Results: type of nutrient and food supplements are essential for a quicker recovery, in addition to their timing and dose. Conclusions: nutrition before, during and after a game or a high-intensity training session plays a fundamental role in the recovery of the basketball player.

INTRODUCCIÓN: Introducción: son escasos los trabajos que ofrecen una solución práctica a los requerimientos nutricionales del baloncesto actual. Este trabajo ofrece una propuesta teórico-práctica, basada en una revisión de la literatura de los últimos años. Objetivos: analizar la fatiga que produce un partido de baloncesto y ofrecer una solución práctica para acelerar la recuperación por medio de la alimentación. Métodos: búsqueda bibliográfica en la base de datos PubMed de revisiones bibliográficas de los últimos 15 años y artículos originales de los últimos 5 años. Resultados: el tipo de nutriente y los suplementos alimenticios, así como la cantidad y el momento de su ingesta, son variables fundamentales para acelerar la recuperación. Conclusiones: la alimentación antes, durante y después de un partido o de una sesión de entrenamiento exigente es fundamental para la rápida recuperación del jugador.

[Unity is strength: nutritional therapy and physical exercise, an essential relationship]. / La unión hace la fuerza: terapia nutricional y ejercicio físico, una relación imprescindible.

INTRODUCTION: Nutrition therapy and exercise form an essential tandem to maintain the functional capacity of patients and, therefore, improve your quality of life. Oral nutritional supplements are part of the medical nutrition treatment. The success of taking nutritional supplements, lies in the therapeutic adherence. The therapeutic adherence is defined by who as "the degree to which the behavior of a patient, in relation to the taking of medication, monitoring a diet or modifying life habits correspond to the recommendations agreed with the health professional ". There are some factors that limit its achievement. Therefore, we must identify them and have tools to solve them so that the patient does not interrupt the prescribed treatment, both from prevention and intervention.

INTRODUCCIÓN: La terapia nutricional y el ejercicio forman un tándem imprescindible para mantener la capacidad funcional de los pacientes y, por ende, mejorar su calidad de vida. Los suplementos nutricionales por vía oral forman parte del tratamiento nutricional médico. El éxito de la toma de suplementos nutricionales, radica en la adherencia terapéutica. La adherencia terapéutica es definida por la OMS como "el grado en el que la conducta de un paciente, en relación con la toma de medicación, el seguimiento de una dieta o la modificación de hábitos de vida se corresponden con las recomendaciones acordadas con el profesional sanitario". Hay una serie de factores que limitan su consecución. Por ello, hay que identificarlos y disponer de herramientas para solventarlos para que el paciente no interrumpa el tratamiento pautado, tanto desde la prevención como la intervención.

Perfil hídrico e consumo de suplementos por frequentadores de academias / Water profile and consumption of supplements by academics / Perfil hídrico y consumo de suplementos por frecuentadores de gimnasios

Objetivo: avaliar o perfil hídrico e o consumo de suplementos de pessoas fisicamente ativas inseridas em academias da cidade Montes Claros, Minas Gerais, Brasil. Método: Trata-se de estudo transversal, realizado com praticantes de atividade física, em 2018. Participaram da pesquisa 200 pessoas, maiores de 20 anos, de ambos os sexos, frequentadores de academias. Realizou-se a avaliação nutricional dos participantes, com aplicação de questionário estruturado, contendo questões relacionadas à prática de atividade física, ingestão hídrica e uso de suplementos alimentares. Resultados: dentre os participantes, 52,5% era do sexo feminino e 65% estavam com peso adequado. Verificou-se que a 71% da população estuda consumia mais que dois litros de água por dia. Dentre os praticantes de atividade física, 60,5% e 99% não faziam o uso de suplementos e anabolizantes, respectivamente. Além disso, 96% não utilizavam ergogênicos. Conclusão: este estudo demonstrou que a população estudada possui ingestão adequada de água e baixo consumo de suplementos, anabolizantes e ergogênicos.(AU)

Objective: to evaluate the water profile and the consumption of supplements by physically active people inserted in academies of the city of Montes Claros, Minas Gerais, Brazil. Method: This is a cross-sectional study, carried out with physical activity practitioners in 2018. The study included 200 people, over 20 years old, of both sexes, attending academies. The nutritional evaluation of the participants was carried out with the application of a structured questionnaire containing questions related to the practice of physical activity, water intake and use of dietary supplements. Results: among the participants, 52.5% were female and 47.5% male. Among all respondents, 65% had normal weight. It was found that 71% of the study population consumed more than two liters of water per day. Among practitioners of physical activity, 60.5% and 99% were not using supplements and steroids, respectively. In addition, 96% of the participants did not use ergogenics. Conclusion: this study demonstrated that the population had adequate water intake and low intake of supplements, steroids and ergogenics.(AU)

Objetivo: evaluar el perfil hídrico y el consumo de suplementos de personas físicamente activas insertadas en gimnasios de la ciudad Montes Claros, Minas Gerais, Brasil. Método: Se trata de un estudio transversal, realizado con practicantes de actividad física, en 2018. Participaron de la investigación 200 personas, mayores de 20 años, de ambos sexos, frecuentadores de gimnasios. Se realizó la evaluación nutricional de los participantes, con aplicación de cuestionario estructurado, conteniendo cuestiones relacionadas a la práctica de actividad física, ingestión hídrica y uso de suplementos alimenticios. Resultados: de los participantes, el 52,5% era del sexo femenino y el 47,5% del sexo masculino. Entre todos los entrevistados, el 65% estaba con peso adecuado. Se verificó que el 71% de la población estudia consumía más de dos litros de agua al día. Entre los practicantes de actividad física, el 60,5% y el 99% no hacían el uso de suplementos y anabolizantes, respectivamente. Además, el 96% de los estudiados no utilizaba ergogénicos. Conclusión: este estudio demostró que la población estudiada posee ingestión adecuada de agua y bajo consumo de suplementos, anabolizantes y ergogénicos.(AU)

Tratamiento nutricional en úlceras por presión y úlceras venosas / Nutritional treatment in pressure and venous ulcers

RESUMEN Las úlceras por presión (UPP) y úlceras venosas (UV) son frecuentes en adultos y adultos mayores. En Chile un 70% de las heridas crónicas corresponden a UV y la prevalencia de UPP en pacientes hospitalizados es de 28%. El objetivo de esta revisión es analizar la evidencia disponible respecto al tratamiento nutricional de individuos con UPP y UV. Estas úlceras tienen diferentes etiologías, pero ambas provocan un aumento de requerimientos energéticos, proteicos y de micronutrientes. La cicatrización de heridas depende de varios factores como: el tipo de úlcera, estado nutricional, patologías presentes, el tipo de curación y el tratamiento médico. La terapia nutricional establece en la mantención o aumento de peso de estos pacientes, administración adecuada de proteínas y suplementación de energía, proteínas o micronutrientes cuando se presente déficit.

ABSTRACT Pressure and venous ulcers are common in adults and the elderly. In Chile, 70% of chronic wounds correspond to venous ulcers and the prevalence of pressure ulcers in hospitalized patients is 28%. The aim of this review was to analyze the available evidence regarding the nutritional treatment of individuals with pressure and venous ulcers. These ulcers have different etiologies, but both produce an increase in energy, protein, and micronutrient requirements. The healing of wounds depends on several factors such as the type of ulcer, nutritional status, current co-morbidities, healing type and medical treatment. Nutritional therapy should be based on weight maintenance or gain of these patients, adequate administration of proteins and energy supplementation, or protein or micronutrients when a deficiency occurs.

Nutritional supplements with omega 3 in retinal disease: Relationship between volume and concentration in commercial products. / Suplementación nutricional con omega 3 en retina: relación entre volumen y concentración en productos comerciales.

OBJECTIVE: To analyse the morphometric characteristics and the concentration of (docosahexaenoic acid) DHA and eicosapentaenoic acid (EPA) of the different nutritional supplements with omega 3 available on the market for retinal disease. MATERIAL AND METHODS: A double-blind study was conducted with a single observer, of the different omega 3 supplementation tablets sample marketed in Spain. The length of the tablet, the concentration of omega 3 in total, as well as DHA and EPA were studied separately using the amount provided by the manufacturer and the volume of the capsule calculated from the development of a specific formula for it. RESULTS: A total of 10 different nutritional supplements were included. The mean of total omega 3, DHA and EPA was 383.10±160.90, 210.72±93.3, and 112.34±140.98mg, respectively. The mean size of the capsules was 14.77±0.19×8.13±0.09mm The smallest sized capsule was that of Oftan macula omega® (Esteve, Barcelona, Spain). Brudymacula® (Brudylab, Barcelona, Spain) and Brudyretina 1.5 g® (Brudylab, Barcelona, Spain) tablets contained more DHA, with Nutrof omega® (Thea Laboratories, Barcelona, Spain) having the lowest concentration of omega 3, DHA and EPA, per tablet. CONCLUSION: There are significant differences in size, volume, quantity, and concentration of omega 3 and its derivatives, between different commercial preparations. Only the knowledge of the characteristics of the nutritional supplements will enable us to provide a more personalised indication of their use for our patients.

Predictive factors of hospital stay, mortality and functional recovery after surgery for hip fracture in elderly patients. / Factores determinantes de estancia hospitalaria, mortalidad y evolución funcional tras cirugía por fractura de cadera en el anciano.

OBJECTIVES: Due to its high prevalence and serious consequences it is very important to be well aware of factors that might be related to medical complications, mortality, hospital stay and functional recovery in elderly patients with hip fracture. MATERIAL AND METHODS: A prospective study of a group of 130 patients aged over 75 years admitted for osteoporotic hip fracture. Their medical records, physical and cognitive status prior to the fall, fracture type and surgical treatment, medical complications and functional and social evolution after hospitalization were evaluated. RESULTS: Patients with greater physical disability, more severe cognitive impairment and those who lived in a nursing home before the fracture had worse functional recovery after surgery. Treatment with intravenous iron to reduce transfusions reduced hospital stay and improved walking ability. Infections and heart failure were the most frequent medical complications and were related to a longer hospital stay. The prescription of nutritional supplements for the patients with real indication improved their physical recovery after the hip fracture CONCLUSIONS: Evaluation of physical, cognitive and social status prior to hip fracture should be the basis of an individual treatment plan because of its great prognostic value. Multidisciplinary teams with continuous monitoring of medical problems should prevent and treat complications as soon as possible. Intravenous iron and specific nutritional supplements can improve functional recovery six months after hip fracture.